Gujarat Kidney & Super Speciality Ltd is launching a ₹250.8 crore mainboard IPO with listing planned on BSE and NSE.
Gujarat Kidney & Super Speciality Ltd is set to enter the Indian stock market with a ₹250.8 crore mainboard Initial Public Offering (IPO). The company’s shares are expected to be listed on both the BSE and NSE, and this is not an SME IPO.
The healthcare company has shown strong financial performance, reporting revenue of ₹4,024 crore in FY25. With a return on equity (ROE) exceeding 36%, Gujarat Kidney & Super Speciality Ltd has attracted significant attention from investors.
The IPO is aimed at strengthening the company’s growth plans and expanding its presence in the healthcare and super-speciality hospital segment.